Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Inc. (NYSE: HUM) will present at the Morgan Stanley Conference on September 15, 2021, at 8:45 a.m. Eastern. Bruce D. Broussard, the President and CEO, will lead the presentation. Interested investors can access a live audio webcast through humana.com. Participants are advised to log in 15 minutes early to ensure system compatibility. Humana is dedicated to advancing health care for its members through comprehensive services including in-home care and data analytics.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.70 per share, payable on October 29, 2021, to shareholders of record as of September 30, 2021. This move underscores Humana's commitment to providing benefits to its investors while enhancing integrated care solutions aimed at improving health outcomes and lowering costs for its members.
Humana continues to support healthcare professionals with resources and tools, ensuring easier navigation through healthcare services.
Humana Inc. (NYSE: HUM) has completed its acquisition of Kindred at Home (KAH), enhancing its position as the largest provider of home healthcare in the U.S. KAH serves over 550,000 patients annually, and its integration into Humana's Home Solutions business aims to improve patient outcomes and satisfaction. The transition to the new CenterWell brand is set for 2022. This acquisition is expected to accelerate clinical innovation and enhance overall healthcare delivery, while also expanding Humana’s workforce with thousands of new caregivers.
Humana Inc. (NYSE: HUM) has released its 2020 Corporate Social Responsibility (CSR) report, highlighting its dedication to health equity and community needs. Amid the COVID-19 pandemic, the company launched new employee benefits, conducted over 6.2 million health screenings, and contributed $50 million in aid to underserved communities. Humana also achieved Energy Star certification for 22 sites, showcased its commitment to health equity by appointing new leadership, and emphasized transparency in its environmental, social, and governance practices moving forward.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $3.0 billion in senior notes, consisting of three tranches: $1.5 billion due 2023, $750 million due 2027, and $750 million due 2032. The expected net proceeds are approximately $2.973 billion. These funds will primarily support the $5.7 billion acquisition of Kindred at Home. If the acquisition is not finalized by January 22, 2022, the company will redeem the 2023 notes. The press release includes cautionary forward-looking statements regarding potential risks affecting business performance.
Humana Inc (NYSE: HUM) has appointed Sue Schick as President of its Group, Military, and Specialty businesses, effective September 1, 2021. Schick, who joined Humana in 2020 and has over 30 years of industry experience, succeeds Chris Hunter, who leaves to pursue other opportunities. Humana aims for ambitious growth in these segments. Currently, the Group, Military, and Specialty business serves 1.2 million employer group members and 12 million Commercial and Medicare Specialty members, while also administering the TRICARE health program for six million U.S. military beneficiaries.
Humana Inc. (NYSE: HUM) has announced a public offering of $3.0 billion in senior notes, comprising $1.5 billion of 0.650% notes due 2023, $750 million of 1.350% notes due 2027, and $750 million of 2.150% notes due 2032. The net proceeds, approximately $2.973 billion, will be used for the acquisition of Kindred at Home, which amounts to about $5.7 billion, inclusive of $1.9 billion in debt assumption. The offerings are scheduled to close on August 3, 2021, and are not conditioned on the acquisition's completion.
Humana reported its 2Q21 results, with GAAP revenue at $20.645 billion, a year-over-year increase from $19.083 billion in 2Q20. However, GAAP pretax income dropped significantly from $2.586 billion in 2Q20 to $738 million in 2Q21. The diluted EPS fell to $4.55 from $13.75, while the non-GAAP adjusted EPS was $6.89, down from $12.56. Despite challenges from the ongoing pandemic, the company revised its FY2021 GAAP EPS guidance to $24.97-$25.47 and maintained its adjusted EPS guidance of $21.25-$21.75. A substantial gain from the acquisition of Kindred at Home is expected, estimated at $1 billion.
XSOLIS has partnered with Humana to implement a real-time predictive analytics platform aimed at enhancing utilization review processes. This collaboration will integrate XSOLIS' CORTEX platform, which analyzes patient data from electronic medical records to streamline interactions between payers and providers. The Precision Utilization Management initiative will allow for 'touchless' status determinations, freeing up clinician time for patient care. Both companies aim to revolutionize medical necessity determinations and improve healthcare efficiency.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
